|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00570 TRAD CHI MED
Nominal 
2.170 -0.030 (-1.364%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 7,463,383 | -10.996% | 16,509,708 | 18,121,861 | 14,304,242 | 19,052,802 |
| Cost of Sales | (3,828,790) | -11.457% | (8,653,400) | (8,847,369) | (7,105,790) | (7,223,639) |
| Gross Profit | 3,634,593 | -10.506% | 7,856,308 | 9,274,492 | 7,198,452 | 11,829,163 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (185,875) | 17.073% | (106,554) | (9,366) | (10,073) | (13,879) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (47) | -94.622% | (950) | (3,699) | (3,479) | (10,749) | |
| Profit / (Loss) before Taxation | (82,939) | -- | 163,109 | 1,224,533 | 840,109 | 2,520,280 | |
| Taxation | (58,821) | -31.035% | (142,338) | 171,537 | (119,144) | (396,856) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 33,842 | -- | 33,296 | (110,870) | 43,521 | (190,566) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (107,918) | -- | 54,067 | 1,285,200 | 764,486 | 1,932,858 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 29,303 | -56.878% | 123,858 | 133,788 | 153,426 | 159,453 |
| Depreciation & Amortisation | 577,233 | 2.806% | 1,130,224 | 1,133,271 | 1,099,397 | 849,597 |
| Directors' Emoluments | -- | -- | 4,402 | 8,932 | 8,971 | 8,003 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -2.140 | -- | 1.070 | 25.520 | 15.180 | 38.380 |
| DPS (cts) | 0.000 | -- | 7.980 | 0.000 | 4.550 | 11.520 |
| Dividend Payout Ratio (%) | -- | -- | 745.794% | -- | 29.974% | 30.016% |
| Cash flow per share ($) | -- | -- | 0.513 | 0.232 | 0.217 | 0.158 |
| NBV per share ($) | 4.111 | -- | 4.211 | 4.202 | 4.005 | 3.916 |
| Remarks: | Real time quote last updated: 22/09/2025 12:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -107,918 |
| %Change | -- |
| EPS / (LPS) | RMB -0.021 |
| NBV Per Share (¥) | RMB 4.111 |